Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ARUK 2022 | Using a human cellular model to investigate inflammatory crosstalk in Alzheimer’s disease

Anne Hedegaard • 2 Mar 2022
ARUK 2022
Alzheimer’s Disease Dementia

Anne Hedegaard, PhD, Univeristy of Oxford, Oxford, UK, explains the development of a human cellular model, derived from induced pluripotent stem cells (iPSCs), which can be used to investigate inflammatory crosstalk among cells in the brain which are thought to be involved in the development of Alzheimer’s disease. This interview took place at the Alzheimer’s Research UK Conference 2022 in Brighton, UK.

More from Anne Hedegaard

0:52
Potential of iPSC models in Alzheimer's disease research
Anne Hedegaard • 2 Mar 2022
1:10
Underlying causes of chronic inflammation in Alzheimer’s disease
Anne Hedegaard • 2 Mar 2022

Related Videos

3:58
Promising FONLISA test for ultrasensitive detection of plasma NfL in Alzheimer’s disease
Madison Honey • 7 Mar 2024
4:12
Updates in Alzheimer’s treatment: the potential of NSC001
Manfred Windisch • 6 Mar 2024
4:44
Influence of genetic risk for psychiatric disorders on dementia
Jenna Najar • 6 Mar 2024
2:31
Barriers to dementia treatment: awareness, accessibility, and affordability
Paola Barbarino • 23 Mar 2024
The content of VJDementia is intended for healthcare professionals